NCT07375147 Transanal vs Transvaginal Rectal Resection for Anterior Rectocele
| NCT ID | NCT07375147 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Rectocele; Female |
| Study Type | INTERVENTIONAL |
| Enrollment | 62 participants |
| Start Date | 2025-06-14 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 62 participants in total. It began in 2025-06-14 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Female patients presenting with obstructed defecation syndrome due to anterior rectocele will be screened according to inclusion and exclusion criteria. Eligible patients will undergo clinical assessment and appropriate investigations including defecography. After informed consent, patients will be randomized into two groups: Stapled Transanal rectal resection or Stapled Transvaginal rectal resection. Improvement in obstructed defecation symptoms and postoperative complications will be compared between the two groups.
Eligibility Criteria
Inclusion Criteria: * Adult female patients complaining of obstructed defecation syndrome with anterior rectocele ≥ 3 cm on straining with failure of conservative management. Exclusion Criteria: * Patients with Slow-transit constipation * Patients with rectocele of \< 3 cm on straining * Patients with complete external rectal prolapse * Evidence of colorectal carcinoma or Inflammatory bowel disease ( IBD) * Previous rectal surgeries * Inability for lifestyle change postoperatively * Previous surgeries for anterior rectocele
Contact & Investigator
Mohamed Tamer, lecteurer
STUDY DIRECTOR
Cairo University
Frequently Asked Questions
Who can join the NCT07375147 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Rectocele; Female. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07375147 currently recruiting?
Yes, NCT07375147 is actively recruiting participants. Contact the research team at drabdelaal90@gmail.com for enrollment information.
Where is the NCT07375147 trial being conducted?
This trial is being conducted at Cairo, Egypt.
Who is sponsoring the NCT07375147 clinical trial?
NCT07375147 is sponsored by Cairo University. The principal investigator is Mohamed Tamer, lecteurer at Cairo University. The trial plans to enroll 62 participants.